Here is Why $NVAX Surged 50% & Closed 27.79% after Neutural Earnings
The Maryland-based company biotech firm $Novavax(NVAX)$ Latest Earnings Results reported a Q1 net loss of $293.9 million and the company would slash its global workforce by about 25%.
Seems investors are wondering how will they going to do $1.5 billion in covid vaccine sales in 2023 after doing only $81 million in Q1.
Hopefully its staff cuts will contribute toward its goal of reducing its annual expenditure by around 40% to 50% by 2024, according to the press release.
Image
However, the outlook of$Novavax(NVAX)$ is Neutural, good news shows the company has positive Phase 2 Topline results show on COVID-Influenza combination, stand-alone influenza and high-dose COVID vaccine candidates demonstrate robust immune responses.
After 35 years of business, Novavax’s Covid antidote remains its only commercially available product.
$Novavax(NVAX)$ soared 27.79% on Tuesday .
Option feld see much more trading enthusiasms, see from the news @Option_Movers There were 116.2K $Novavax(NVAX)$ option contracts traded on Tuesday, surging over 270% from the previous day. Call options account for 61% of overall option trades. Particularly high volume was seen for the $10 strike call option expiring May 12, with 7,874 contracts trading.with 50,343 contracts trading.
Unusual Options Activity, Source: Market Chameleon
Regarding to $Novavax(NVAX)$’s option strategies, the public info shares If NVAX stock price at expiration is at or above $11.00, a spread strategy has a 42% upside potential.
Option Profit Calculator for NVAX Call Spread at 12-May-23 Expiration
The optimal stock price for this option strategy is to close at or above $11.00 on the expiration date, May 12, 2023. In that scenario, both calls would be in-the-money, so the spread would be worth the maximum value of 3.00. That would equate to the potential upside of +37% for this call spread with 3 days left to expiration.
The maximum gain will be realized if the stock price is at or above 11.00. The maximum gain is $0.81
The breakeven point is at 10.19, which is 7.7% below the current spot price.
The maximum loss will occur when the stock price is at or below 8. The max loss is $2.19.
I’m learning about trading options……
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Despite the challenges, Novavax's Phase 2 results for COVID-Influenza combination and influenza vaccines look promising
NVAX oversold again...! Eyes on ACRX tomorrow, out tonight from ACRX
Novavax stock skyrocketed by 27.79% on Tuesday, and option trading saw a significant surge in enthusiasm
I hope the staff cuts at Novavax help them reduce expenses and meet their targets by 2024
Whoa, Novavax reported a massive Q1 net loss and plans to cut a quarter of its workforce
Check for tomorrow morning's conference details on the Novavax website.
Something new about this . Never heard of it .look into it
Great ariticle, would you like to share it?
Ok
🍜